1 completed, 1 terminated, 1 withdrawn. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Terminated 1, Withdrawn 1 |
Follow Techsomed Medical Technologies LTD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures BioTraceIO 360 - Hepatocellular Carcinoma, Metastatic Liver Cancer | Not applicable | Terminated | Techsomed Medical Technologies LTD | 4 | 2023-09-05 | 2025-09-15 |
| Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2) BioTraceIO 360 - Hepatocellular Carcinoma, Metastatic Liver Cancer | Not applicable | Withdrawn | Techsomed Medical Technologies LTD | 2023-07-01 | 2023-11-27 | |
| Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures BioTraceIO Lite - Carcinoma, Hepatocellular, Metastatic Liver Cancer | Completed | Techsomed Medical Technologies LTD | 65 | 2021-09-24 | 2023-04-18 |
Carcinoma, Hepatocellular (3) · Liver Neoplasms (3)
United States (2)